Ann: Entitlement Offer Closing Date Extended, page-33

I wouldnt say its super sp lifting, but mark did mention today the hurdles needing to jump over in the near future... the testing site approvals, country by country paperwork to carry out the trials... i think these little announcements will give investors confidence things are happening... even if not as quickly as we'd hoped.

i found charmaines comments around the murdoch studies interesting. Aside from it taking a long time, she touched on what types of DMD mutations our drug might work best on... but summarised saying unlike the tailored GT drugs, targeting just a few, ours targets 100%.

mark also said it could be possible to go it alone and market it to the small number of Drs withdmd kids in the ircare.

GP said hes working w ppmd? to create a standard of care for the kids. And thought there might be an opp w JP morgan??

please do correct me, this was my take from today.

I believe MD wants us to be a super aussie pharma, raking in all profit ourselves.